IPF (idiopathic pulmonary fibrosis) is a condition in which over a period of time the lung tissue becomes thickened, stiff, and
scarred. The development of the scar tissue is called fibrosis. As the lung tissue becomes scarred and thicker, the lungs lose
their ability to transfer oxygen into the bloodstream. As a result, the brain and other organs don't get the oxygen they need.
Symptoms
- shortness of breath
- chronic dry hacking cough
- fatigue and weakness
- discomfort in the chest
- loss of appetite
- rapid weight loss
Causes
The origin and development of IPF is still not completely understood. The current thinking is that there is an abnormal
response to microscopic injury which ultimately results in scarring. There are also genetic factors that may contribute to the
development of IPF:
- Smoking
- Environmental dust/pollutants
- Viral infections
- Genetics
Western Medicine Treatment
The clinical course of idiopathic pulmonary fibrosis (IPF) is highly variable and may be difficult to predict. As a result, strategies
to treat IPF are highly individualized, based upon the specific patients’ medical history and other conditions. Typical standards
of care may include:
- prescription therapies
- supplemental oxygen
- pulmonary rehabilitation
- lung transplantation (Lung transplantation remains the most viable course of treatment to extend the lives of those with IPF)
Adopted from Wei Laboratories, Inc.
